Kolumne, ORE

Original-Research: Nabaltec AG - von NuWays AG Einstufung von NuWays AG zu Nabaltec AG Unternehmen: Nabaltec AG ISIN: DE000A0KPPR7 Anlass der Studie: Q3 Review Empfehlung: BUY seit: 24.11.2023 Kursziel: EUR 31,00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Q3 review: better-than-feared margin thanks to boehmite; chg Q3 sales decreased by 12% yoy to EUR 49.8m (eNuW: EUR 50.5m) as a result of continued weak end markets, which left a particularly strong mark on the group's Specialty Alumina segment (-24% yoy to EUR 14.1m). Positively, demand for its high-margin product boehmite, which has been weak for more than one year, has begun to pick up.

24.11.2023 - 09:31:39

Original-Research: Nabaltec AG (von NuWays AG): BUY


Original-Research: Nabaltec AG - von NuWays AG

Einstufung von NuWays AG zu Nabaltec AG

Unternehmen: Nabaltec AG
ISIN: DE000A0KPPR7

Anlass der Studie: Q3 Review
Empfehlung: BUY
seit: 24.11.2023
Kursziel: EUR 31,00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Christian Sandherr

Q3 review: better-than-feared margin thanks to boehmite; chg
 
Q3 sales decreased by 12% yoy to EUR 49.8m (eNuW: EUR 50.5m) as a result of
continued weak end markets, which left a particularly strong mark on the
group's Specialty Alumina segment (-24% yoy to EUR 14.1m). Positively, demand
for its high-margin product boehmite, which has been weak for more than one
year, has begun to pick up. This explains the "only" 6% sales decline of
the Functional Fillers segment to EUR 53.7m. In fact, monthly sales volumes
should have improved from ~450t to roughly 600t as customers across Eastern
Europe are gradually (but slowly) ramping up battery production volumes and
Asian customers are slowly reverting back to regular orders.
 
Q3 EBIT came in better than feared at EUR 4.6m (eNuW: EUR 3.4m), a 9.3% margin
driven by the improved product mix (higher boehmite and lower Specialty
Alumina sales shares) and slightly lower input costs (vs. previous
quarters) that compensated for general labour cost inflation.
 
FY guidance confirmed. At the beginning of August, the company adjusted its
FY23 guidance to a 4-6% yoy sales decline (eNuW: 5% with an EBIT margin of
6-8% (eNuW new: 7.8%). While we still expect Nabaltec to meet the mid-point
of the sales guidance, the upper end of the EBIT margin guidance should be
in reach (9M: 8.4% margin), implying a margin of only 5.8% in Q4.
 
Balance sheet remains strong. At the end of Q3, Nabaltec's balance sheet
featured roughly EUR 15m net cash (EUR 93m cash, EUR 15m short-term financial
assets and EUR 90m debt). During the next 2-3 years, the company looks set to
invest roughly EUR 45m into expanding production capacities of boehmite and
APYRAL, a gap filler that is mixed with glues used in battery packs/EVs to
redirect heat away from the
cells. Fully utilized boehmite and APYRAL capacity expansions would yield EUR
65-70m incremental sales and EUR 16m EBIT.
 
What to expect from 2024e. Nabaltec is seen to return to slight growth,
thanks to stabilizing sales of core products, environmental friendly flame
retardants, and a gradually improving order momentum for boehmite and
APYRAL as European EV and battery productions are ramping up. The resulting
improvement of the product mix and slight raw material/energy price
deflation should allow for further expanding
margins. Beyond 2024e, core products should also return to structural
growth, in our view.
 
Nabaltec remains a BUY with an unchanged EUR 31 PT, based on FCFY 2024e.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28395.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de